ReviewCureus2026

Beyond Glucose Control: A Comprehensive Review of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure, Chronic Kidney Disease, and Nonalcoholic Fatty Liver Disease.

Alexander R Sosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.